Automatic substitution with biosimilars by pharmacies should start next month in Germany – How will it work?
On 16 Aug 2019, the GSAV came into force. This new law also included legislation with the aim to increase the market
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
On 16 Aug 2019, the GSAV came into force. This new law also included legislation with the aim to increase the market
During the pandemic, the G-BA introduced special regulations for hospital care. Based on their good experiences with these, the G-BA has now
Welcome again! We are extending the short excursion to quality assurance today with a look at minimum case numbers in Germany. In
Welcome to the second post in the quality assurance series, focusing on the hot topic of ATMPs! Next week, I’ll be focusing
Biosimilars are biological drugs that are highly similar to another biological medicine, the so-called originator. The biosimilars have no clinically meaningful differences to